Mutated Pseudomonas Exotoxins with Reduced Antigenicity
European Patent
10179539.1
Filed on 2006-07-25
10179539.1
Filed on 2006-07-25
Mutated Pseudomonas Exotoxins with Reduced Antigenicity
European Patent
10179520.1
Filed on 2006-07-25
10179520.1
Filed on 2006-07-25
METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF ESPHAGEAL ADENOCARCINOMAS
European Patent
08838376.5
Filed on 2008-10-10
08838376.5
Filed on 2008-10-10
Biologically Active Macrolides, Compositions, and Uses Thereof
US Patent 8,741,947
Filed on 2010-08-06
Filed on 2010-08-06
MELANOMA ANTIGENS
European Patent
10010559.2
Filed on 1995-04-21
10010559.2
Filed on 1995-04-21
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
European Patent
10010354.8
Filed on 2001-01-26
10010354.8
Filed on 2001-01-26
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
European Patent
10010389.4
Filed on 2001-01-26
10010389.4
Filed on 2001-01-26
NOVEL MHC CLASS II RESTRICTED T CELL EPITOPES FROM THE CANCER ANTIGEN NY ESO-1
European Patent
10010353.0
Filed on 2001-01-26
10010353.0
Filed on 2001-01-26
Identification of Novel Broadly Cross-Reactive HIV 1 Neutralizing Human Monoclonal Antibodies Using Sequential Antigen Panning Of Phage Display Libraries
US Application 12/869,198
Filed on 2010-08-26
Filed on 2010-08-26
Therapy With A Chimeric Molecule And A Pro-Apoptotic Agent
Patent Cooperation Treaty
PCT/US2010/046382
Filed on 2010-08-23
PCT/US2010/046382
Filed on 2010-08-23